- CA$2.97m
- CA$7.69m
- CA$22.05m
- 61
- 72
- 74
- 78
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 26.2 | 24 | 29.7 | 27.3 | 22 |
Cost of Revenue | |||||
Gross Profit | 7.51 | 9.03 | 11.1 | 10.8 | 7.58 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 26.8 | 24.9 | 30.5 | 26.9 | 22.3 |
Operating Profit | -0.522 | -0.868 | -0.822 | 0.356 | -0.302 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.434 | -1.23 | -1.71 | 0.21 | -0.619 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.434 | -0.554 | -1.71 | 0.222 | -1.72 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.434 | -0.554 | -1.71 | 0.222 | -1.72 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.434 | -0.554 | -1.71 | 0.222 | -1.72 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.015 | 0.009 | -0.021 | 0.007 | -0.044 |